Albert Koong, MD, PhD, becomes the new Chief Scientific Officer at UT MD Anderson Cancer Center.
Key Details
- 1Albert Koong, MD, PhD, formally appointed as UT MD Anderson's Chief Scientific Officer effective June 1, 2026.
- 2Previously served as interim CSO since January 1, 2026.
- 3Role includes overseeing laboratory and clinical research, fostering innovation, and supporting AI-driven scientific advancement.
- 4Has led as division head of Radiation Oncology and contributed significantly to GI radiation oncology research.
- 5Recognized with honors such as Fellow of the American College of Radiology (FACR) and American Society for Radiation Oncology (FASTRO).
Why It Matters
Leadership at a prominent cancer center, especially with expertise in radiation oncology and ties to AI advancement, influences radiology and imaging research directions and collaborations. This appointment further signals ongoing integration of AI in cancer science by institutional leaders.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.